These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22356635)

  • 1. The psoriasis xenograft SCID mouse model: a tool in translational research.
    Boehncke WH
    Br J Dermatol; 2012 Mar; 166(3):473. PubMed ID: 22356635
    [No Abstract]   [Full Text] [Related]  

  • 2. Translating clinical activity and gene expression signatures of etanercept and ciclosporin to the psoriasis xenograft SCID mouse model.
    Norsgaard H; Svensson L; Hagedorn PH; Moller K; Olsen GM; Labuda T
    Br J Dermatol; 2012 Mar; 166(3):649-52. PubMed ID: 22050597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic therapy for psoriasis: the tumor necrosis factor inhibitors infliximab and etanercept.
    Weinberg JM; Saini R
    Cutis; 2003 Jan; 71(1):25-9. PubMed ID: 12553627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etanercept does not have an apoptosis-inducing effect on psoriatic keratinocytes.
    Tatlican S; Arikok A; Gulbahar O; Eren C; Cevirgen B; Eskioglu F
    J Dermatolog Treat; 2010 Sep; 21(5):306-10. PubMed ID: 19878038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of von Zumbusch generalized pustular psoriasis with cyclosporine after eruption post etanercept injection.
    Ephrem G; Jour G; Smith BL
    J Med Liban; 2011; 59(3):168-9. PubMed ID: 22259908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the type and length of tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis.
    Wu JJ; Poon KY; Bebchuk JD
    J Drugs Dermatol; 2013 Aug; 12(8):899-903. PubMed ID: 23986163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis options abound. Ongoing research on Enbrel and Raptiva supports their use in psoriasis treatment.
    Krueger GG
    Health News; 2004 Jan; 10(1):10-1. PubMed ID: 15002383
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficiency and safety of etanercept after acute hepatitis induced by infliximab for psoriasis.
    Kluger N; Girard C; Guillot B; Bessis D
    Acta Derm Venereol; 2009; 89(3):332-4. PubMed ID: 19479148
    [No Abstract]   [Full Text] [Related]  

  • 9. Effective control of psoriasis by etanercept in a patient with HCV-related diseases.
    Piccolo D; Di Cesare A; Fargnoli MC; Paoloni M; Vecchiotti S; Peris K
    Eur J Dermatol; 2008; 18(4):459-60. PubMed ID: 18573723
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of Crohn disease in a patient on etanercept for psoriasis.
    Ahmad K; Rogers S
    Br J Dermatol; 2007 Aug; 157(2):396. PubMed ID: 17573878
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of systemic cold contact urticaria with etanercept in a patient with psoriasis.
    Gualdi G; Monari P; Rossi MT; Crotti S; Calzavara-Pinton PG
    Br J Dermatol; 2012 Jun; 166(6):1373-4. PubMed ID: 22212112
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term efficacy of etanercept for psoriasis in daily practice.
    Van Lümig PP; Driessen RJ; Boezeman JB; Van De Kerkhof PC; De Jong EM
    Br J Dermatol; 2012 Feb; 166(2):445-7. PubMed ID: 21910699
    [No Abstract]   [Full Text] [Related]  

  • 13. Adalimumab vs. etanercept in psoriasis.
    Downs AM
    Clin Exp Dermatol; 2007 Sep; 32(5):593. PubMed ID: 17692064
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biologics in the treatment of psoriasis].
    Dissemond J; Grabbe S
    MMW Fortschr Med; 2006 Sep; 148(38):42-4. PubMed ID: 17036963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: results of a prospective, multicenter, open-label study.
    Gottlieb AB; Kalb RE; Blauvelt A; Heffernan MP; Sofen HL; Ferris LK; Kerdel FA; Calabro S; Wang J; Kerkmann U; Chevrier M
    J Am Acad Dermatol; 2012 Oct; 67(4):642-50. PubMed ID: 22153792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic therapy for psoriasis--the first wave: infliximab, etanercept, efalizumab, and alefacept.
    Weinberg JM; Saini R; Tutrone WD
    J Drugs Dermatol; 2002 Dec; 1(3):303-10. PubMed ID: 12851990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized pustular psoriasis of Zambusch: case report of successful disease control with cyclosporine and etanercept.
    Vine K; Votava HJ; Smith BL
    Cutis; 2012 Sep; 90(3):132-6. PubMed ID: 23094312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etanercept: effectiveness and safety data of a retrospective study.
    Antoniou C; Vergou T; Dessinioti C; Stratigos AJ; Avgerinou G; Stavropoulos P; Katsambas A
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1113-5. PubMed ID: 20673305
    [No Abstract]   [Full Text] [Related]  

  • 19. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept.
    Caldarola G; De Simone C; Carbone A; Tulli A; Amerio P; Feliciani C
    Int J Immunopathol Pharmacol; 2009; 22(4):961-6. PubMed ID: 20074459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study.
    Woolf RT; Smith CH; Robertson K; Barker JN
    Br J Dermatol; 2010 Oct; 163(4):889-92. PubMed ID: 20854408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.